THERAPEUTICS
Review: high frequency repetitive transcranial magnetic stimulation improves symptoms of treatment resistant major depression
| The first 150 words of the full text of this article appear below. |
What is the clinical efficacy of high frequency repetitive transcranial magnetic stimulation in people with treatment resistant depression?
The primary outcome was clinical response defined using a global rating scale (eg, "much improved" or "very much improved" on the Clinical Global Impression Scale (CGI)) or a set level of improvement on a continuous depression rating scale (eg, improvement of 50% or greater from baseline to end of treatment on the Hamilton Depression Rating Scale (HAMD) or the Montgomery–Asberg Depression Rating Scale (MADRS)). Secondary outcomes included depressive symptoms (end point symptom scores) and remission (defined as a score on a depression rating scale within the normal range—eg, HAMD score
7, MADRS score
12 or a global rating of not depressed or equivalent on the CGI).
Systematic review with meta-analysis.
MEDLINE, EMBASE, PsycINFO and the Cochrane Central Register of Controlled Trials were searched from inception to May 2008 for randomised controlled trials
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
